Matteo Duca

5PUBLICATIONS
38CO-AUTHORS
Gene and molecular therapyMolecular targetsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Federico Nichetti, Marta Brambilla, Matteo Duca

|Jul 24, 2023
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.

Andrea Vingiani, Luca Agnelli, Matteo Duca

|Nov 07, 2022
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples.

Iolanda Capone, Fabio Bozzi, Gian Paolo Dagrada

|Feb 08, 2022
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors.

Matteo Duca, Darren Wan-Teck Lim, Vivek Subbiah

|Oct 07, 2021
Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors.

Sylvie Rottey, Jeffrey Clarke, Kyaw Aung

Pageof 1

Frequent Collaborators

3 joint publications

Alberta Piccolo

3 joint publications

Daniele Lorenzini

3 joint publications

Elena Tamborini

3 joint publications

Silvia Damian